| scholarly article | Q13442814 |
| P356 | DOI | 10.2217/PGS.11.102 |
| P698 | PubMed publication ID | 21961650 |
| P50 | author | Alessio Squassina | Q43086266 |
| Mirko Manchia | Q43301077 | ||
| Donatella Congiu | Q43303034 | ||
| Raffaella Ardau | Q43303040 | ||
| George P Patrinos | Q52340356 | ||
| Joseph Borg | Q55692569 | ||
| Giovanni Severino | Q99371890 | ||
| Caterina Chillotti | Q114369988 | ||
| Konstantinos Mitropoulos | Q114511540 | ||
| P2093 | author name string | Maria Del Zompo | |
| Marianthi Georgitsi | |||
| Marta Costa | |||
| P2860 | cites work | Finding the missing heritability of complex diseases | Q22122198 |
| The genetics of bipolar disorder: genome ‘hot regions,’ genes, new potential candidates and future directions | Q22251105 | ||
| Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication | Q22253024 | ||
| The acid-activated ion channel ASIC contributes to synaptic plasticity, learning, and memory | Q24296641 | ||
| Replication and extension of genome-wide association study results for obesity in 4923 adults from northern Sweden | Q24648857 | ||
| The role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesis | Q24651407 | ||
| Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder | Q24655630 | ||
| PLINK: a tool set for whole-genome association and population-based linkage analyses | Q24677407 | ||
| Haploview: analysis and visualization of LD and haplotype maps | Q27860955 | ||
| Acid-sensing ion channel 2 (ASIC2) modulates ASIC1 H+-activated currents in hippocampal neurons | Q28505408 | ||
| GCTA: a tool for genome-wide complex trait analysis | Q29547216 | ||
| Is Glycogen Synthase Kinase-3 a Central Modulator in Mood Regulation? | Q30475816 | ||
| Does lithium treatment still work? Evidence of stable responses over three decades | Q33832738 | ||
| The heterotetrameric architecture of the epithelial sodium channel (ENaC). | Q33888043 | ||
| A common mechanism of action for three mood-stabilizing drugs | Q34128871 | ||
| Pharmacogenomics of mood stabilizers in the treatment of bipolar disorder | Q34146222 | ||
| A diagnostic interview: the schedule for affective disorders and schizophrenia | Q34269355 | ||
| Association study of the INPP1, 5HTT, BDNF, AP-2beta and GSK-3beta GENE variants and restrospectively scored response to lithium prophylaxis in bipolar disorder | Q34540294 | ||
| Glycogen synthase kinase-3beta, mood stabilizers, and neuroprotection | Q34692767 | ||
| Genetic linkage in bipolar disorder | Q35673089 | ||
| Association between the ACCN1 gene and multiple sclerosis in Central East Sardinia | Q35794487 | ||
| Molecular effects of lithium | Q35912157 | ||
| Lithium - a continuing story in the treatment of bipolar disorder | Q36099532 | ||
| Investigating responders to lithium prophylaxis as a strategy for mapping susceptibility genes for bipolar disorder | Q36157435 | ||
| Acid-sensing ion channels: advances, questions and therapeutic opportunities. | Q36557438 | ||
| Acid-sensing ion channel-1a in the amygdala, a novel therapeutic target in depression-related behavior | Q37262543 | ||
| Looking at lithium: molecular moods and complex behaviour | Q37327911 | ||
| Maintenance treatment in bipolar disorder: a reassessment of lithium as the first choice | Q37524497 | ||
| A genomewide association study of response to lithium for prevention of recurrence in bipolar disorder. | Q37536783 | ||
| Molecular neurobiology of bipolar disorder: a disease of 'mood-stabilizing neurons'? | Q39276505 | ||
| Long-term response to lithium salts in bipolar illness is influenced by the glycogen synthase kinase 3-beta -50 T/C SNP. | Q40448135 | ||
| RASSF4/AD037 is a potential ras effector/tumor suppressor of the RASSF family. | Q40485735 | ||
| Number of subunits comprising the epithelial sodium channel | Q41689667 | ||
| Serotonin transporter gene associated with lithium prophylaxis in mood disorders. | Q43932430 | ||
| Association studies of the BDNF and the NTRK2 gene polymorphisms with prophylactic lithium response in bipolar patients | Q46238863 | ||
| Graphic representation of the life course of illness in patients with affective disorder. | Q52069749 | ||
| Interacting genes in lithium prophylaxis: preliminary results of an exploratory analysis on the role of DGKH and NR1D1 gene polymorphisms in 199 Sardinian bipolar patients. | Q54716070 | ||
| Convergence of linkage, association and GWAS findings for a candidate region for bipolar disorder and schizophrenia on chromosome 4p | Q57410903 | ||
| A locus for bipolar affective disorder on chromosome 4p | Q57416170 | ||
| The Wellcome trust UK–Irish bipolar affective disorder sibling-pair genome screen: first stage report | Q58132723 | ||
| The PDLIM5 gene and lithium prophylaxis: An association and gene expression analysis in Sardinian patients with bipolar disorder | Q58875312 | ||
| P433 | issue | 11 | |
| P921 | main subject | bipolar disorder | Q131755 |
| P304 | page(s) | 1559-1569 | |
| P577 | publication date | 2011-10-03 | |
| P1433 | published in | Pharmacogenomics | Q15724625 |
| P1476 | title | Evidence for association of an ACCN1 gene variant with response to lithium treatment in Sardinian patients with bipolar disorder | |
| P478 | volume | 12 |
| Q57077038 | A gene co-expression module implicating the mitochondrial electron transport chain is associated with long-term response to lithium treatment in bipolar affective disorder |
| Q52149898 | A glutamatergic network mediates lithium response in bipolar disorder as defined by epigenome pathway analysis. |
| Q31156844 | ASIC2 subunits facilitate expression at the cell surface and confer regulation by PSD-95. |
| Q26829975 | Acid-sensing ion channels in pain and disease. |
| Q58875252 | An Introduction to Pharmacogenomics and Personalized Medicine |
| Q54966148 | Antidepressant drug-specific prediction of depression treatment outcomes from genetic and clinical variables. |
| Q34804607 | Assessment of Response to Lithium Maintenance Treatment in Bipolar Disorder: A Consortium on Lithium Genetics (ConLiGen) Report |
| Q28082445 | Emergent treatments based on the pathophysiology of bipolar disorder: A selective review |
| Q44841212 | Family-based exome-sequencing approach identifies rare susceptibility variants for lithium-responsive bipolar disorder |
| Q47779120 | From direct to indirect lithium targets: a comprehensive review of omics data. |
| Q36699480 | Genetic influences on response to mood stabilizers in bipolar disorder: current status of knowledge |
| Q36746449 | Genetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association study |
| Q50343363 | Genetics of bipolar disorder |
| Q37199024 | Genome-wide association study identifies SESTD1 as a novel risk gene for lithium-responsive bipolar disorder |
| Q39390032 | Genomics of Lithium Action and Response |
| Q38170458 | Individualizing clozapine and risperidone treatment for schizophrenia patients |
| Q38903498 | Insulin-like Growth Factor 1 Differentially Affects Lithium Sensitivity of Lymphoblastoid Cell Lines from Lithium Responder and Non-responder Bipolar Disorder Patients |
| Q57618969 | KLF10gene expression is associated with high fetal hemoglobin levels and with response to hydroxyurea treatment in β-hemoglobinopathy patients |
| Q38955537 | Lithium Pharmacogenetics: Where Do We Stand? |
| Q88959461 | Lithium Treatment for Agitation in Alzheimer's disease (Lit-AD): Clinical rationale and study design |
| Q28081249 | Lithium in the treatment of bipolar disorder: pharmacology and pharmacogenetics |
| Q38758778 | Lithium-responsive genes and gene networks in bipolar disorder patient-derived lymphoblastoid cell lines |
| Q30576923 | Localization and behaviors in null mice suggest that ASIC1 and ASIC2 modulate responses to aversive stimuli. |
| Q33885418 | Long-term response to mood stabilizer treatment and its clinical correlates in patients with bipolar disorders: a retrospective observational study |
| Q30745171 | Multivariate Genetic Correlates of the Auditory Paired Stimuli-Based P2 Event-Related Potential in the Psychosis Dimension From the BSNIP Study |
| Q34551182 | Pathway analysis using information from allele-specific gene methylation in genome-wide association studies for bipolar disorder |
| Q38139479 | Pharmacogenetics of mood disorders: what clinicians need to know |
| Q92255814 | Pharmacogenomic Characterization in Bipolar Spectrum Disorders |
| Q47648687 | Pharmacogenomics education and research at the Department of Pharmacy, University of Patras, Greece |
| Q38097534 | Pharmacogenomics of bipolar disorder |
| Q97427309 | Potential pharmacogenomic targets in bipolar disorder: considerations for current testing and the development of decision support tools to individualize treatment selection |
| Q55002697 | Prediction of response to drug therapy in psychiatric disorders. |
| Q33777973 | Response to lithium in bipolar disorder: clinical and genetic findings |
| Q38192967 | Role of lithium augmentation in the management of major depressive disorder |
| Q93196912 | SCN11A mRNA levels in female bipolar disorder PBMCs as tentative biomarker for distinct patient sub-phenotypes |
| Q88780379 | The Role of Pharmacogenomics in Bipolar Disorder: Moving Towards Precision Medicine |
| Q28554117 | ePGA: A Web-Based Information System for Translational Pharmacogenomics |
Search more.